Current Value
$110.941 Year Return
Current Value
$110.941 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTG | 0.01% | $1.93B | 0.07% |
STPZ | -0.07% | $443.85M | 0.2% |
COM | 0.22% | $210.46M | 0.72% |
STOT | -0.23% | $254.22M | 0.45% |
CANE | -0.29% | $11.17M | 0.29% |
SCHO | 0.31% | $10.92B | 0.03% |
SHYD | 0.48% | $332.11M | 0.35% |
USFR | 0.52% | $18.61B | 0.15% |
DBC | 0.53% | $1.26B | 0.87% |
VTIP | 0.64% | $15.19B | 0.03% |
XBIL | -0.68% | $781.34M | 0.15% |
OUNZ | -0.71% | $1.74B | 0.25% |
IBD | 0.71% | $391.63M | 0.43% |
BAR | -0.72% | $1.11B | 0.1749% |
AAAU | -0.75% | $1.56B | 0.18% |
FLMI | 0.76% | $745.34M | 0.3% |
SGOL | -0.78% | $5.21B | 0.17% |
CTA | 0.89% | $1.07B | 0.76% |
GLDM | -0.91% | $15.87B | 0.1% |
GLD | -0.92% | $100.91B | 0.4% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -21.90% | $200.94M | 0.85% |
TAIL | -20.82% | $94.90M | 0.59% |
CLIP | -19.22% | $1.51B | 0.07% |
VIXM | -19.15% | $22.99M | 0.85% |
TBLL | -18.72% | $2.12B | 0.08% |
GBIL | -14.50% | $6.37B | 0.12% |
IVOL | -13.64% | $341.06M | 1.02% |
AGZD | -12.14% | $98.57M | 0.23% |
TPMN | -11.87% | $30.86M | 0.65% |
XONE | -9.83% | $629.16M | 0.03% |
SGOV | -9.81% | $50.94B | 0.09% |
BILZ | -9.31% | $852.10M | 0.14% |
ULST | -7.59% | $592.71M | 0.2% |
BIL | -7.46% | $41.78B | 0.1356% |
BOXX | -7.22% | $6.97B | 0.19% |
IBTF | -6.37% | $1.98B | 0.07% |
TFLO | -5.62% | $6.73B | 0.15% |
FTSD | -5.46% | $233.24M | 0.25% |
SHYM | -5.42% | $355.87M | 0.35% |
KCCA | -5.38% | $109.01M | 0.87% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BBH | 59.22% | $345.62M | 0.35% |
IBB | 56.86% | $5.59B | 0.45% |
FHLC | 53.11% | $2.46B | 0.084% |
XLV | 52.78% | $34.28B | 0.09% |
VHT | 52.62% | $15.49B | 0.09% |
IYH | 52.56% | $2.76B | 0.39% |
IXJ | 52.14% | $3.80B | 0.41% |
PBE | 52.03% | $233.59M | 0.58% |
FBT | 51.73% | $1.05B | 0.54% |
RSPH | 51.39% | $728.37M | 0.4% |
PPH | 51.10% | $544.00M | 0.36% |
FXH | 48.06% | $891.10M | 0.62% |
IHE | 47.32% | $562.06M | 0.39% |
PINK | 47.23% | $132.39M | 0.5% |
DHS | 46.21% | $1.27B | 0.38% |
FDL | 45.95% | $5.64B | 0.43% |
XPH | 45.27% | $155.51M | 0.35% |
HDV | 44.78% | $11.29B | 0.08% |
FVD | 44.44% | $9.12B | 0.61% |
XBI | 44.35% | $5.19B | 0.35% |
Finnhub
Gilead Sciences Inc: Ny ag James- my office and 48 ags secured $202 million from Gilead Sciences - X post...
Finnhub
SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year anti-HIV jab, lenacapavir. Research shows the shot could help end Aids in...
SeekingAlpha
Parnassus Value Equity Fund Q2 2025 Commentary
Finnhub
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Gilead Sciences, Inc. for violations of the securities...
Yahoo
The WHO’s Director-General described the policy guidelines for Gilead’s twice-yearly drug as the “next best thing” in the absence of a vaccine.
Yahoo
FOSTER CITY, Calif., July 14, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Gilead researchers and collaborators will present new Phase 3 PURPOSE trial data at IAS 2025 showing that twice-yearly lenacapavir (Yeztugo®) was effective and well tolerated among a broad range of populations who need or want pre-exposure prophylaxis (PrEP) for HIV prevention, including pregnant and lactating women, adolescents and young people, and supports lenacapavir dosing recommendations for peopl
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AMGN | 48.02% | $159.71B | -10.03% | 3.12% |
BMY | 45.83% | $96.34B | +17.91% | 5.18% |
PFE | 42.79% | $144.12B | -12.89% | 6.69% |
GSK | 42.68% | $77.41B | -0.98% | 4.17% |
ABBV | 42.66% | $338.30B | +13.98% | 3.37% |
PEP | 41.60% | $185.88B | -17.26% | 4.07% |
INCY | 41.16% | $13.55B | +8.92% | 0.00% |
MTD | 41.08% | $24.81B | -12.12% | 0.00% |
BIIB | 40.75% | $19.50B | -39.93% | 0.00% |
GMAB | 40.59% | $13.20B | -19.14% | 0.00% |
SNY | 40.59% | $118.29B | -3.19% | 4.52% |
UTHR | 39.88% | $13.43B | -9.04% | 0.00% |
PAYX | 39.70% | $51.98B | +18.65% | 2.80% |
NVS | 39.36% | $229.68B | +9.71% | 3.29% |
JNJ | 39.31% | $377.32B | +5.08% | 3.20% |
ADP | 39.05% | $123.14B | +25.02% | 2.00% |
QGEN | 38.90% | $10.46B | +12.29% | 0.52% |
DOX | 38.58% | $9.87B | +9.48% | 2.26% |
TMO | 38.29% | $160.56B | -21.91% | 0.39% |
SYY | 38.29% | $37.67B | +8.22% | 2.65% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HMY | -0.02% | $8.96B | +52.38% | 1.21% |
LFMD | -0.04% | $514.47M | +69.21% | 0.00% |
TZOO | -0.10% | $144.68M | +58.64% | 0.00% |
CMBM | -0.10% | $14.33M | -75.12% | 0.00% |
VSA | -0.10% | $12.16M | +21.20% | 0.00% |
NGVC | 0.10% | $923.29M | +71.92% | 1.16% |
ATOM | -0.11% | $144.92M | +14.56% | 0.00% |
VRCA | 0.12% | $75.38M | -90.26% | 0.00% |
CCJ | -0.14% | $32.71B | +43.89% | 0.15% |
TEN | -0.15% | $586.58M | -26.80% | 7.74% |
LEU | -0.18% | $3.68B | +357.71% | 0.00% |
DHT | -0.19% | $1.79B | +1.18% | 7.28% |
LION | 0.20% | $1.95B | -17.53% | 0.00% |
MNDY | 0.20% | $14.77B | +22.99% | 0.00% |
PRIM | -0.21% | $4.72B | +67.54% | 0.34% |
DXCM | 0.24% | $33.46B | -24.49% | 0.00% |
NVGS | 0.27% | $1.07B | -9.28% | 1.29% |
ETN | 0.28% | $140.98B | +10.17% | 1.08% |
AEM | 0.29% | $60.44B | +59.95% | 1.35% |
EW | -0.30% | $45.92B | -12.54% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HUSA | -13.98% | $20.46M | -9.15% | 0.00% |
BTCT | -10.31% | $29.39M | +101.55% | 0.00% |
AIFU | -9.81% | $17.40M | +87.81% | 0.00% |
STRL | -9.01% | $7.34B | +86.67% | 0.00% |
CARM | -8.27% | $18.84M | -64.22% | 0.00% |
TLN | -8.14% | $12.83B | +116.38% | 0.00% |
FVRR | -7.77% | $969.91M | +12.54% | 0.00% |
CNK | -6.70% | $3.43B | +40.21% | 0.54% |
FIX | -6.64% | $19.15B | +68.22% | 0.27% |
ANET | -6.52% | $136.10B | +20.27% | 0.00% |
BE | -6.48% | $6.03B | +78.54% | 0.00% |
MELI | -6.20% | $120.67B | +36.48% | 0.00% |
VRT | -6.19% | $47.53B | +41.90% | 0.11% |
LMB | -5.94% | $1.74B | +132.77% | 0.00% |
DFDV | -5.89% | $361.15M | +2,667.20% | 0.00% |
PULM | -5.74% | $23.92M | +218.89% | 0.00% |
ASC | -5.66% | $415.58M | -49.00% | 6.77% |
IAG | -5.41% | $4.05B | +71.12% | 0.00% |
STNG | -5.37% | $2.33B | -40.74% | 3.56% |
CEG | -5.32% | $102.17B | +53.13% | 0.46% |
Double maintains 15 strategies that include GILD - Gilead Sciences, Inc.